| Title | Pregnancy outcome of women transfused during pregnancy with blood products inadvertently obtained from donors treated with acitretin. | | Author(s) | Han JY, Choi JS, Chun JM, Park HD, Lee SY, Kim CH, Park Q, Nava-Ocampo AA, Koren G | | Institution | Korean Motherisk Program, Department of Obstetrics and Gynecology. | | Source | J Obstet Gynaecol 2009 Nov; 29(8):694-7. | | Abstract | We assessed the pregnancy outcome of nine women inadvertently transfused with acitretin-contaminated blood products in South Korea. A total of 18 women matched to cases by age, gravidity, and singleton- or twin-pregnancy, and who were transfused with blood products not contaminated with acitretin, was also recruited. There were nine babies born in the case group. No differences (p > 0.05) were observed between cases and controls in the gestational age at delivery (38.3 +/- 1.6 weeks vs 37.8 +/- 2.2 weeks), birth weight (3,146 +/- 874 g vs 3,106 +/- 568 g), rate of pre-term deliveries (22.2% vs 11.1%) and rate of low birth weight (<2,500 g) (33.3% vs 16.7%). There was no case of malformation or neurological abnormalities born in either group. In conclusion, inadvertent exposure to acitretin-contaminated blood products was not associated with adverse pregnancy outcomes, probably because of the removal of acitretin and etretinate during the manufacturing process of blood products. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 19821659 |
|
